- Home
- USAU vs AMRN Comparison
USAU vs AMRN Comparison
Compare USAU & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.16
HOLD
Current Price
$14.61
Company Overview
Basic Information| Metric | USAU | AMRN |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.5M | 339.8M |
| IPO Year | 2020 | 1998 |
Fundamental Metrics
Financial Performance| Metric | USAU | AMRN |
|---|---|---|
| Price | $14.16 | $14.61 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $22.83 | $12.00 |
| AVG Volume (30 Days) | ★ 277.8K | 79.9K |
| Earning Date | 03-16-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | $17,402,000.00 | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $7.38 | $0.39 |
| 52 Week High | $23.72 | $20.90 |
Technical Indicators
Market Signals| Indicator | USAU | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 32.57 | 43.84 |
| Support Level | $12.06 | $13.63 |
| Resistance Level | $14.39 | $14.55 |
| Average True Range (ATR) | 0.97 | 0.80 |
| MACD | -0.42 | -0.03 |
| Stochastic Oscillator | 1.46 | 22.16 |
Price Performance
Historical Comparison USAU
AMRN
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.